Thiosulfate And Selpercatinib
Sep 29, 2022•16 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Sodium thiosulfate is now FDA-approved to minimize the risk of ototoxicity in some children receiving cisplatin.
Selpercatinib is granted a 'regular' approval for RET-fusion (+) NSCLC and an accelerated approval for other solid tumors.
For the best experience, listen in Metacast app for iOS or Android